AVBT — Avisa Diagnostics Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Avisa Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.004 | 0.022 | 1.8 | 0.426 | 0.11 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.001 | 0 | 0.065 | 0.065 | 0.001 |
Prepaid Expenses | |||||
Total Current Assets | 0.004 | 0.022 | 1.88 | 0.494 | 0.114 |
Net Property, Plant And Equipment | — | — | 0.019 | 0.029 | 0.009 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.004 | 0.022 | 4.32 | 0.523 | 0.122 |
Accounts Payable | |||||
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.124 | 0.069 | 0.191 | 0.356 | 0.494 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.124 | 0.083 | 0.191 | 0.356 | 0.648 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.12 | -0.061 | 4.13 | 0.167 | -0.526 |
Total Liabilities & Shareholders' Equity | 0.004 | 0.022 | 4.32 | 0.523 | 0.122 |
Total Common Shares Outstanding |